5-Fluoro-MET

5-Fluoro-MET (5F-MET, 5-fluoro-N-methyl-N-ethyltryptamine) is a psychedelic tryptamine derivative related to drugs such as 5-Fluoro-DMT and N-Methyl-N-ethyltryptamine (MET). It acts as an agonist at the 5-HT2A receptor with an EC50 of 20.6 nM and produces a head-twitch response in animal studies. Ring fluorination in this case increases efficacy at 5-HT2A, with 5F-MET having an efficacy of 87.6% vs 5-HT, vs 36.2% for the partial agonist MET. It is claimed to have antidepressant activity.[1]

5-Fluoro-MET
Clinical data
Other names5F-MET
Identifiers
IUPAC name
  • N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethanamine
PubChem CID
Chemical and physical data
FormulaC13H17FN2
Molar mass220.291 g·mol−1
3D model (JSmol)
SMILES
  • CCN(C)CCC1=CNC2=C1C=C(C=C2)F
InChI
  • InChI=1S/C13H17FN2/c1-3-16(2)7-6-10-9-15-13-5-4-11(14)8-12(10)13/h4-5,8-9,15H,3,6-7H2,1-2H3
  • Key:XRWQULAXCLVBPP-UHFFFAOYSA-N

See also

References
  1. WO 2021/168082, Kruegel AC, Sporn J, "Specific Tryptamines for use in the Treatment of Mood Disorders.", published 26 August 2021, assigned to Gilgamesh Pharmaceuticals, Inc..


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.